Harm reduction International find in this comprehensive regional overview of harm reduction options, a means to support the 15.6M people who inject drugs and have been impacted by Hepatitis C & HIV as a result.
Public Health England argue that governments from regional to national level, must combat the spread of infections such as hepatitis C through enabling recovery solutions amongst people who inject drugs.
In response to the growing number of opioid-related deaths, this paper presents findings that indicate benefits of controlled Heroine assisted treatment (HAT) over methadone substitutions.
INPUD, MPact and NSWP outline the many ways in which stigma and discrimination impact on key populations and their families and provide recommendations for redress.
The report urges the government to decouple responses to drug use from the crime and justice system, instead increasing the offer of treatment and support services.
The EMCDDA and COPOLAD report on a recent workshop organised with CELAC countries to assess current trends and developments related to drugs in the region.
The EMCDDA explores how data on drug use are captured through surveys of targeted populations in recreational settings, identifies gaps and points to technical innovations.
Data within this annual report finds a reduction of opium poppy cultivation (2017-18) in Afghanistan, despite the continuous large regional distribution of opium in southern regions (69%).
EHRA present within this report, a plan to strategically integrate harm reduction programmes into national health and social systems across Eastern Europe and Central Asia.
Norway shows the objectives of the 2009 Political Declaration and Plan of Action are, to a high extent, directly reflected in the 2016 Outcome Document.
The authors provide an overview of the uses of tramadol in the region, highlighting regulatory flaws and cautioning against the negative impact of drug scheduling.
.pdf )
